Email Icon Facebook icon Twitter Icon GooglePlus Icon Contact

User Top Menu

Second-generation antipsychotics did not improve outcomes and increased costs for patients with Alzheimer disease and psychosis.

Seitz DP, Gruneir A, Rochon PA
ACP J Club. 2008 Mar-Apr; 148(2):53. PMID: 18311883. Pubmed